Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer

Pathol Res Pract. 2021 Feb 12;219:153374. doi: 10.1016/j.prp.2021.153374. Online ahead of print.ABSTRACTRSK4 refers to one Ser/Thr protein kinase functioning downstream pertaining to the signaling channel of protein kinase (MAPK) stimulated by Ras/mitogen. RSK4 can regulate numerous substrates impacting cells' surviving state, growing processes and proliferating process. Thus, dysregulated RSK4 active state display a relationship to several carcinoma categories, covering breast carcinoma, esophageal squamous cell carcinoma, glioma, colorectal carcinoma, lung carcinoma, ovarian carcinoma, leukemia, endometrial carcinoma, and kidney carcinoma. Whether RSK4 is a tumor suppressor gene or one oncogene remains controversial. No specific inhibiting elements for RSK4 have been found. This review briefs the existing information regarding RSK4 activating process, the function and mechanism of RSK4 in different tumors, and the research progress and limitations of existing RSK inhibitors. RSK4 may be a potential target of molecular therapy medicine in the future.PMID:33621918 | DOI:10.1016/j.prp.2021.153374
Source: Pathology, Research and Practice - Category: Pathology Authors: Source Type: research